Showing results (121-130 of 240) with videos related to
Sort By:
Pageof 24
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulantJames D Douketis, Summer Syed, Na Li, et al.Journal of Thrombosis and Haemostasis : JTH|October 6, 2022
Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedureJoseph R Shaw, Na Li, Joanne Nixon, et al.Journal of Thrombosis and Thrombolysis|June 23, 2019
Assessment of warfarin algorithms for hospitalized adults: searching for a safe dosing strategyJessica L Cohen, Elena Thompson, Liron Sinvani, et al.Journal of Thrombosis and Haemostasis : JTH|May 19, 2006
Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registryA C Spyropoulos, A G G Turpie, A S Dunn, et al.The American Journal of Medicine|April 25, 2016
Validation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical PatientsM Todd Greene, Alex C Spyropoulos, Vineet Chopra, et al.Cardiology Research|February 25, 2022
Healthcare Resource Utilization for Oral Anticoagulant Reversal Therapies in Non-Valvular Atrial Fibrillation/Venous Thromboembolism PatientsAlex C Spyropoulos, Briain O Hartaigh, Zhun Cao, et al.Thrombosis Research|July 4, 2012
Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: a pediatric experienceA Moruf, A C Spyropoulos, T Q Schardt, et al.Clinical Therapeutics|September 1, 2004
Management patterns and outcomes of patients with venous thromboembolism in the usual community practice settingVincent J Willey, Michael F Bullano, Ole Hauch, et al.Chest|July 24, 2008
The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)James D Douketis, Peter B Berger, Andrew S Dunn, et al.Journal of the American Heart Association|November 10, 2021
Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINERGary E Raskob, Alex C Spyropoulos, Theodore E Spiro, et al.Pageof 24